Per-patient Comparison of [<sup>68</sup>Ga]-FAPI-46 Versus [<sup>18</sup>F]FDG as PET Tracers in ER-positive Breast Cancer: Study Design of a Single-centre Prospective Study. [PDF]
Lenaerts M +11 more
europepmc +1 more source
Translational Theranostics in Glioblastoma: FAPI-46 as a Precision Medicine Tool. [PDF]
Jeanjean P +14 more
europepmc +1 more source
The Role of <sup>68</sup>Ga-FAPi PET/CT in Staging and Restaging of Breast Cancer Subtypes with Limited <sup>18</sup>F-FDG Uptake. [PDF]
Beydağı G +7 more
europepmc +1 more source
Coronary artery disease imaging with total-body PET. [PDF]
Clark LE +7 more
europepmc +1 more source
Comparative Performance of <sup>18</sup>F-FDG PET/CT and <sup>68</sup>Ga-FAPI PET/CT in TENIS Syndrome in Treated Differentiated Thyroid Carcinoma. [PDF]
Bhagirath Bhad J +9 more
europepmc +1 more source
Dual-tracer PET/CT protocol with [<sup>18</sup>F]FDG and [<sup>68</sup>Ga]Ga-FAPI-46 outperforms single-tracer PET/CT with [<sup>18</sup>F]FDG in different cancer types, resulting in larger functional and gross tumor volume. [PDF]
Wegen S +9 more
europepmc +1 more source
68Ga-FAPI-04 PET/CT has high diagnostic efficacy in Tg-positive and Tg-negative differentiated thyroid cancer. [PDF]
Mou L +5 more
europepmc +1 more source
Prospective comparison of [<sup>68</sup>Ga]Ga-FAPI-04 PET/MRI, [<sup>18</sup>F]FDG PET/CT, and contrast-enhanced MRI for predicting pathologic complete response after neoadjuvant chemotherapy in breast cancer. [PDF]
Luo Y +16 more
europepmc +1 more source
Hybrid Molecular Imaging Using PET/CT and PET/MRI in Inflammatory Bowel Disease: Current Applications, Challenges, and Future Perspectives. [PDF]
Li Y +6 more
europepmc +1 more source
Clinical and research applications of fibroblast activation protein-α inhibitor tracers: a review. [PDF]
Desaulniers M, Rousseau É, Pabst KM.
europepmc +1 more source

